American Society of Clinical Oncology (ASCO)

Lundbeck to showcase progress across its movement disorders pipeline with data in multiple system atrophy and Parkinson's disease at MDS® 2026

2026-10-02 15:05 1957

* Late-breaking Phase III MASCOT oral presentation will characterize the clinical profile and diversity of participants in Lundbeck's ongoing global Phase III trial investigating amlenetug in multiple system atrophy (MSA) * New research across clinical trial endpoints, biomarkers, diagnostic t...

Akeso Announces First Patient Enrolled in Global Phase III Trial of Cadonilimab Versus Nivolumab in First-Line Gastric Cancer

2026-09-28 10:05 3398

HONG KONG, Sep. 27, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that the first patient has been enrolled in COMPASSION-37 (AK104-311), a global, multicenter Phase III head-to-head trial evaluating cadonilimab, Akeso's first-in-class PD-1/CTLA-4 bispecific...

STARTRADER Named Best Fintech Forex Broker at Forex Expo Dubai 2026

2026-09-24 19:03 2228

The award, presented at the ninth edition of the region's leading trading gathering, caps a year of continuous product expansion. DUBAI, UAE, Sept. 24, 2026 /PRNewswire/ -- STARTRADER was named Best Fintech Forex Broker at the Forex Expo Dubai Awards, organised by HQMENA and presented during For...

STARTRADER Named Best Fintech Forex Broker at Forex Expo Dubai 2026

2026-09-24 18:49 1796

The award, presented at the ninth edition of the region's leading trading gathering, caps a year of continuous product expansion. DUBAI, UAE, Sept. 24, 2026 /PRNewswire/ -- STARTRADER was named Best Fintech Forex Broker at the Forex Expo Dubai Awards, organised by HQMENA and presented during For...

Totaria Highlights Magnesium Nutrition Awareness During Healthy Aging Month

2026-09-15 21:12 1934

AURORA, Colo., Sept. 15, 2026 /PRNewswire/ -- As September marks Healthy Aging Month  in the United States, premium American nutritional supplement brand Totaria is raising awaren...

Sorbent to acquire Kenvue's Stayfree and Carefree business in Australia and New Zealand

2026-09-14 11:58 2512

MELBOURNE, Australia, Sept. 14, 2026 /PRNewswire/ -- Sorbent Paper Company Pty Ltd ("Sorbent") has signed an agreement with Kenvue's Singaporean subsidiary to acquire its Stayfree and Carefree feminine care business in Australia and New Zealand. Following completion of the transaction, the busine...

Fashion Summit (HK) 2026 "Code the Fashion Forward" at the Hong Kong Palace Museum: Global Fashion Leaders, Innovators, and Local Design Talents Gather, Sharing Insights to Co-create a Green and Smart New Chapter in Fashion

2026-09-11 17:39 3648

HONG KONG, Sept. 11, 2026 /PRNewswire/ -- Organised by the Clothing Industry Training Authority (CITA) and sponsored by the Cultural and Creative Industries Development Agency (CCIDA) of the Government of the Hong Kong Special Administrative Region, the "Fashion Summit (HK) 2026" was successfully...

MTE HANOI 2026 - GLOBAL TRENDS IMPACTING VIETNAM HOSPITALITY AND REAL ESTATE

2026-09-10 18:28 3152

HO CHI MINH CITY, Vietnam, Sept. 10, 2026 /PRNewswire/ -- Global challenges and uncertainty are clouding markets worldwide, yet Vietnam's hospitality sector has been one of the strongest performers globally, supported by strong interest from both international visitors and investors. How can it b...

CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum

2026-08-31 20:38 4917

CS2009 Achieved Key Clinical Validations for Efficacy and Safety As of August 2026, updated data further confirmed the favorable safety profile of CS2009 and demonstrated strengthened efficacy across multiple key cohorts compared with the data presented at ASCO in May 2026. With expanded patient...

CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum

2026-08-27 22:15 6353

CS2009 Achieved Key Clinical Validations for Efficacy and Safety As of August 2026, updated data further confirmed the favorable safety profile of CS2009 and demonstrated strengthened efficacy across multiple key cohorts compared with the data presented at ASCO in May 2026. With expanded patient...

Fosun Pharma Announces 2026 Interim Results

2026-08-25 20:44 3236

Globalization Accelerates Value Realization of Innovative Drugs SHANGHAI, Aug. 25, 2026 /PRNewswire/ -- On August 25, Fosun Pharma ("the Company", stock code: 600196.SH; 02196.HK) announced its interim results for 2026. In the first half of 2026 ("the Reporting Period", or 1H2026), the Company r...

Singapore Prepares to Host a Major Week for Offshore Energy as World Offshore Week 2026 Approaches

2026-08-25 15:59 2252

SINGAPORE, Aug. 25, 2026 /PRNewswire/ -- In just over four weeks, World Offshore Week 2026, part of the FPSO Network, will bring the offshore oil, energy and marine industries together at Singapore EXPO on 23–24 September 2026.

Senhwa Completes Enrollment in Phase 1b CX-5461 Expansion Trial; CSR Expected in Q1 2027

2026-08-25 14:56 1486

TAIPEI, Aug. 25, 2026 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492) today announced that it has completed enrollment in its Phase 1b expansion trial evaluating pidnarulex (CX-5461) monotherapy in patients with advanced solid tumors harboring BRCA1/2, PALB2, or other homologous recombinati...

3S Bio Announces 2026 Interim Results: Innovation-Driven, Win-Win Collaboration, and Sustainable Growth

2026-08-21 15:39 5835

SHANGHAI, Aug. 21, 2026 /PRNewswire/ -- 3S Bio (01530.HK) today announced its interim results for the first half of 2026. During the period, the Company recorded revenue of RMB 4.53 billion, representing a year-over-year growth of 3.9%. Net profit attributable to equity holders of the Company rea...

GSK's Blenrep (belantamab mafodotin) combinations approved in Singapore for treatment of relapsed/refractory multiple myeloma

2026-08-19 10:00 2179

* Two head-to-head phase III trials demonstrated superior efficacy, including overall survival versus a daratumumab-based triplet in DREAMM-7 * Blenrep, a first-in-class anti-BCMA ADC, could transform treatment as early as first relapse where additional effective treatment options are needed [...

CARsgen Therapeutics Announces 2026 Interim Results

2026-08-19 08:15 3377

SHANGHAI, Aug. 18, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, has announced its 2026 Interim Results. Business Highlights * Cash and cash equivalents were around RMB1,400 million as of June ...

Early Bird Tickets Now on Sale | ICOMIA & Sinoexpo Unveil 2027 ICOMIA World Marinas Conference (Shanghai) Preliminary Programme

2026-08-18 18:42 2178

SHANGHAI, Aug. 18, 2026 /PRNewswire/ -- The International Council of Marine Industry Associations (ICOMIA) and Conference hostSinoexpo Informa Markets are pleased to announce the Preliminary Conference Programme for theICOMIA World Marinas Conference 2027 (IWMC2027), taking place in Shanghai, Chi...

Kelun-Biotech Announces 2026 Interim Results

2026-08-17 19:18 5579

CHENGDU, China, Aug. 17, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", Stock Code: 6990.HK) announces its unaudited consolidated results for the period ended 30 June 2026 (the "Reporting Period"). Key information is as follows: * Re...

Yochanra®, the World's First Innovative Drug to Overcome FGFR Inhibitor Resistance, Makes Its Global Debut in China

2026-08-07 14:44 4074

NANJING, China and GAITHERSBURG, Md., Aug. 7, 2026 /PRNewswire/ -- TransThera Sciences' Yochanra® is the first drug independently developed in China to address the longstanding global challenge of acquired resistance to FGFR inhibitor therapy in patients with cholangiocarcinoma. On 6 August 2026,...

Herbalgy Trophy Ignites Hong Kong as Football Fever Sweeps the City

2026-08-06 10:46 3917

Juventus Defeat Chelsea FC 1–0 "Goal-Getter Giveaway" Opens the Door to World-Class Football1, While 5 Children Fulfil Their Dreams as Player Mascots HONG KONG, Aug. 6, 2026 /PRNewswire/ -- The Herbalgy Trophy: Chelsea FC vs Juventus, the headline of the Hong Kong Football Festival 2026 proudly ...

12345 ... 8